Vaccines in Flux: The FDA's Approval and What It Means for Public Health The US Food and Drug Administration's (FDA) approval of updated Covid 19 vaccines targeting the dominant XFG variant has brought a mix of relief and uncertainty to the public health landscape.
Manufacturers can now begin shipping doses, but vaccination recommendations and insurance coverage remain unclear.
One striking aspect is the disconnect between the FDA's approval process and the lack of clarity on who should receive these shots.